Investigation of Urinary Biomarkers for the Detection of Prostate Cancer
Key facts
- Who runs it
- Novosanis NV
- Where
- Belgium1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Withdrawn
- Started
- Dec 2023
- Ended
- Dec 2023
- Type of study
- Interventional
- Treatments tested
- Colli-Pee UAS devices
- Record updated
- 13 November 2023
- Why it stopped
- Study is part of PhD trajectory and currently the trajectory is in the final phases without the official start of this recruitment.
Who can take part
- Age
- 18 years and older
- Sex
- Men only
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Being at least 18 years old
- Being able to understand and read Dutch
- For cancer patients: being diagnosed with prostate cancer
- For healthy volunteers: being male
Who cannot take part
- For cancer patients: suffering from a blood cancer
- For healthy volunteers: diagnosed with cancer
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of this study is to investigate and possibly validate urinary biomarkers for prostate cancer. During this study the focus will be on aberrations of selected genes as prognostic or predictive value has been shown for these genes in tissue, CTC or blood derived cfDNA. Proteins will be explored in urine as well.
Read full original descriptionShow less
This is a prospective study in which urine samples will be collected from healthy volunteers and urine samples and a blood sample from cancer patients with prostate cancer. The participants will be asked to provide a urine sample collected with the ColliPee® device and fill out an online questionnaire to collect usability data. Thereafter, the urine sample will be aliquoted to be used in the study to investigate the different urinary analytes.
The group in the trial
- Sample collectionTreatment being tested
This is a prospective study in which urine samples will be collected from healthy volunteers and urine samples and a blood sample from cancer patients with breast- or prostate cancer. The participants will be asked to provide a urine sample collected with the ColliPee® device and fill out an online questionnaire to collect usability data.
Treatment: Colli-Pee UAS devices
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 13 November 2023